NEWPORT BEACH, Calif., Jan. 14, 2021 /PRNewswire/ -- Hoag Memorial Hospital Presbyterian is building upon its personalized, science-based approach to cancer care with the launch of its Molecular Imaging and Therapy Program, led by nationally recognized expert Gary A. Ulaner, M.D., Ph.D.

Dr. Ulaner, who is dual board-certified in radiology and nuclear medicine, recently joined Hoag Family Cancer Institute from Memorial Sloan Kettering Cancer Center where he served as the PET/CT expert on the Breast Cancer and Myeloma Disease Management Teams. He is bringing with him multiple innovative clinical trials, some of which are federally-funded by the National Institutes of Health, that use molecular imaging to detect cancer at a cellular level, well before traditional imaging. Using molecular imaging to target cancer cells, Dr. Ulaner will also be conducting trials to evaluate the efficacy of targeted radiation therapy ("liquid radiation") to then treat cancer.

"There have been tremendous recent advancements in cancer therapies which 'target' a specific molecule on the cancer cell," Dr. Ulaner said. "I am so happy to help bring these advanced trials to Orange County, and specifically, the Hoag community. Hoag's Molecular Imaging and Therapy Program is helping to pioneer the most sensitive imaging methods to date to advance research and more superiorly treat Hoag cancer patients."

Molecular imaging uses radiotracers, a kind of tumor-specific dye that "lights up" in a positron emission tomography-computerized tomography (PET/CT) scan. This allows physicians to find a cancer cell's exact location and determine the best course of treatment for that specific cancer. Molecular imaging is also used to monitor a cancer treatment's effectiveness.

"One of the advantages of molecular imaging is that it can direct oncologists to the precise location of a cancer, rather than guessing where it might be," Dr. Ulaner said. "These technologies also show promise in helping us to evaluate a patient's immune cells to determine who will respond best to immunotherapy."

Hoag Family Cancer Institute is a leader in cancer therapy in Orange County, bringing innovative treatments and programs to patients–including Hoag's Precision Medicine Program, Cell Therapy Program for solid tumors, and some of the most advanced surgical techniques and radiation therapy available in the United States, including the recent addition of the ViewRay MRIdian™ linear accelerator. "By formalizing a program around Molecular Imaging and Therapy, Hoag continues to underscores its commitment to truly personalized cancer therapy," said Burton L. Eisenberg, M.D., F.A.C.S., executive medical director of Hoag Family Cancer Institute and the Grace E. Hoag Executive Medical Director Endowed Chair.

More People on the Move